Waukesha, WI, United States of America

Emmanuel Israel Fuentes


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emmanuel Israel Fuentes: Innovator in Computer-Aided Drug Discovery

Introduction

Emmanuel Israel Fuentes is a notable inventor based in Waukesha, Wisconsin. He has made significant contributions to the field of computer-aided drug discovery, holding two patents that showcase his innovative approach to identifying optimal candidate compounds.

Latest Patents

Fuentes' latest patents focus on a computer device designed for detecting optimal candidate compounds. The invention involves a method that utilizes a plurality of samples, including cell lines and biomarkers, to create a plate map configuration. This configuration provides locations for samples exposed to various concentrations of candidate compounds, forming concentration gradients. The method generates phenotypic profiles for each concentration gradient over time, allowing for the detection of the optimal candidate compound through a comparison criterion applied to the compound profiles. This invention also encompasses a corresponding computer device, computer program, and computer program product.

Career Highlights

Emmanuel Fuentes is currently employed at Molecular Devices Corporation, where he continues to advance his research and development efforts in the field of biotechnology. His work is instrumental in enhancing the efficiency of drug discovery processes.

Collaborations

Fuentes collaborates with talented individuals such as Gopal Biligeri Avinash and Robert John Graves, contributing to a dynamic research environment that fosters innovation.

Conclusion

Emmanuel Israel Fuentes exemplifies the spirit of innovation in the realm of computer-aided drug discovery. His patents reflect a commitment to improving methodologies in identifying candidate compounds, ultimately contributing to advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…